Baystreet Staff - Monday, June 15, 2026 Ventripoint Diagnostics Ltd 10:22 AM EST - Ventripoint Diagnostics Ltd : Announced its support for the Global Congenital Heart Disease Alliance (“GCHDA”), a newly forming industry alliance dedicated to accelerating the development, commercialization, and global adoption of congenital cardiovascular technologies. Ventripoint Diagnostics Ltd shares V.VPT are trading unchanged at $0.11. Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=VPT%3ACA&qmodStoryID=4634613431525168
